메뉴 건너뛰기




Volumn 88, Issue 2, 2008, Pages 162-163

Streptomycin
[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; BETA LACTAM; CYCLOSERINE; ETHAMBUTOL; ISONIAZID; KANAMYCIN; RIFAMPICIN; STREPTOMYCIN; STREPTOMYCIN SULFATE;

EID: 43249113855     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-9792(08)70027-1     Document Type: Review
Times cited : (15)

References (7)
  • 1
    • 33750324953 scopus 로고    scopus 로고
    • Pyrazinamide, ethambutol, ethionamide, and aminoglycosides
    • Rom W., and Garay S. (Eds), Lippincott Williams & Wilkins, Philadelphia, PA
    • Chan E., et al. Pyrazinamide, ethambutol, ethionamide, and aminoglycosides. In: Rom W., and Garay S. (Eds). Tuberculosis. 2nd edition (2003), Lippincott Williams & Wilkins, Philadelphia, PA 773-789
    • (2003) Tuberculosis. 2nd edition , pp. 773-789
    • Chan, E.1
  • 2
    • 4644229320 scopus 로고    scopus 로고
    • Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?
    • Di Perri G., and Bonora S. Which agents should we use for the treatment of multidrug-resistant Mycobacterium tuberculosis?. J Antimicrob Chemother 54 (2004) 593-602
    • (2004) J Antimicrob Chemother , vol.54 , pp. 593-602
    • Di Perri, G.1    Bonora, S.2
  • 3
    • 0030855743 scopus 로고    scopus 로고
    • In-vitro activities of aminoglycosideaminocyclitols against mycobacteria
    • Ho Y., et al. In-vitro activities of aminoglycosideaminocyclitols against mycobacteria. J Antimicrob Chemother 40 (1997) 27-32
    • (1997) J Antimicrob Chemother , vol.40 , pp. 27-32
    • Ho, Y.1
  • 4
    • 0029761216 scopus 로고    scopus 로고
    • In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Curr
    • Rastogi N., et al. In vitro activities of fourteen antimicrobial agents against drug susceptible and resistant clinical isolates of Mycobacterium tuberculosis and comparative intracellular activities against the virulent H37Rv strain in human macrophages. Curr. Microbiol 33 (1996) 167-175
    • (1996) Microbiol , vol.33 , pp. 167-175
    • Rastogi, N.1
  • 5
    • 0031035789 scopus 로고    scopus 로고
    • Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice?
    • Lounis N., et al. Which aminoglycoside or fluoroquinolone is more active against Mycobacterium tuberculosis in mice?. Antimicrob Agents Chemother 41 (1996) 607-610
    • (1996) Antimicrob Agents Chemother , vol.41 , pp. 607-610
    • Lounis, N.1
  • 6
    • 2942536119 scopus 로고    scopus 로고
    • Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases
    • Peloquin C., et al. Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases. Clin Infect Dis 38 (2004) 1538-1544
    • (2004) Clin Infect Dis , vol.38 , pp. 1538-1544
    • Peloquin, C.1
  • 7
    • 0012778571 scopus 로고    scopus 로고
    • Experimental chemotherapy of mycobacterial diseases
    • Gangadharan P., and Jenkins P. (Eds), Chapman and Hall
    • Grosset J., and Ji B. Experimental chemotherapy of mycobacterial diseases. In: Gangadharan P., and Jenkins P. (Eds). Mycobacteria: II. Chemotherapy (1998), Chapman and Hall 51-97
    • (1998) Mycobacteria: II. Chemotherapy , pp. 51-97
    • Grosset, J.1    Ji, B.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.